Join
Live feed
·
INSIDERFilingvia Quantisnow
Kiromic BioPharma Inc. logo

CEO Bersani Pietro bought $19,530 worth of shares (6,000 units at $3.25), increasing direct ownership by 5% to 138,845 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KRBP· Kiromic BioPharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KRBP (Kiromic BioPharma Inc.) and more on Quantisnow.